Temperature-stable tuberculosis vaccine safe, prompts immune response in first-in-human trial
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune system. The Phase 1 trial was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. A non-temperature stable form of the candidate previously had been tested in
Published 3 months ago
News Articles
More
Filters
Filters
Time & Location
Sources are mostly out of (0)
Bias Distribution
50% of the sources are Center
L 25%
C 50%
R 25%
See less detail
